Proton beam therapy and localised prostate cancer: current status and controversies

被引：0
作者：
J A Efstathiou
P J Gray
A L Zietman
机构：
[1] Massachusetts General Hospital,Department of Radiation Oncology
[2] Harvard Medical School,undefined
来源：
British Journal of Cancer | 2013年 / 108卷
关键词：
proton beam; radiation; prostate cancer; quality of life; cost; evidence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Proton therapy is a promising, but costly, treatment for prostate cancer. Theoretical physical advantages exist; yet to date, it has been shown only to be comparably safe and effective when compared with the alternatives and not necessarily superior. If clinically meaningful benefits do exist for patients, more rigorous study will be needed to detect them and society will require this to justify the investment of time and money. New technical advances in proton beam delivery coupled with shortened overall treatment times and declining device costs have the potential to make this a more cost-effective therapy in the years ahead.
引用
收藏
页码：1225 / 1230
页数：5
相关论文
共 333 条
  • [1] Arcangeli S(2012)Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer Int J Radiat Oncol Biol Phys 84 1172-1178
  • [2] Strigari L(2010)Comparison of out-of-field photon doses in 6MV IMRT and neutron doses in proton therapy for adult and pediatric patients Phys Med Biol 55 2879-2891
  • [3] Gomellini S(2011)Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer Int J Radiat Oncol Biol Phys 81 e325-e334
  • [4] Saracino B(2011)Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer J Clin Oncol 29 2020-2026
  • [5] Petrongari MG(2009)Reduction of the secondary neutron dose in passively scattered proton radiotherapy, using an optimized pre-collimator/collimator Phys Med Biol 54 6065-6078
  • [6] Pinnaro P(2008)Secondary neutrons in clinical proton radiotherapy: a charged issue Radiother Oncol 86 165-170
  • [7] Pinzi V(2011)Clinical consequences of relative biological effectiveness (RBE) variations in proton radiotherapy of the prostate, brain, and liver Int J Radiat Oncol Biol Phys 81 S725-S726
  • [8] Arcangeli G(2012)Proton radiotherapy for parameningeal rhabdomyosarcoma: clinical outcomes and late effects Int J Radiat Oncol Biol Phys 82 635-642
  • [9] Athar BS(2008)Comparative analysis of secondary malignancy risk in patients treated with proton therapy versus conventional photon therapy Int J Radiat Oncol Biol Phys 72 S8-1009
  • [10] Bednarz B(2011)Acute and late toxicity after dose escalation to 82 GyE using conformal proton radiation for localized prostate cancer: initial report of American College of Radiology Phase II study 03-12 Int J Radiat Oncol Biol Phys 81 1005-e31
12345678910